These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1531987)

  • 1. Evaluation of the inotropic function at rest and the effect of enoximone in heart transplanted recipients. Assessment by left ventricular endsystolic pressure volume relationship.
    Heublein B; Auricchio A; Wagenbreth I; Haverich A; Dieterich HA
    J Cardiovasc Surg (Torino); 1992; 33(1):21-7. PubMed ID: 1531987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoximone: true inotropic effects? Do they cause ischemia? Analysis of end-systolic pressure-volume relations using the conductance (volume) catheter technique.
    Thormann J; Hueting J; Kremer P; Wissemann J; Mitrovic V; Dieterich HA; Schlepper M
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1403-15. PubMed ID: 2149060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
    Herrmann HC; Ruddy TD; William G; Strauss HW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
    Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
    J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
    Installe E; De Coster P; Gonzalez M; Brichant C; Lessire H; Cauwe F
    Eur Heart J; 1991 Sep; 12(9):985-93. PubMed ID: 1834466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proof for piroximone's inotropic influence; can it safely be used in coronary artery disease? Analysis of end-systolic pressure-volume relations (conductance technique).
    Thormann J; Liebrich A; Mitrovic V; Strasser R; Dieterich HA; Schlepper M
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):50-62. PubMed ID: 1383631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of clinical intervention on pressure-volume relationships--the conductance (volume) technique.
    Thormann J
    Eur Heart J; 1992 Nov; 13 Suppl E():69-79. PubMed ID: 1478213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose enoximone therapy in pre-transplant patients: hemodynamic, echocardiographic, and neurohumoral findings.
    Park JW; Heinzler R; Wirtz JH; Fieten-Rumswinkel M; Braun P; May E; Hetzer R; Heinrich KW
    Z Kardiol; 1994; 83 Suppl 2():49-53. PubMed ID: 8091824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac function after orthotopic heart transplantation: response to postural changes, exercise, and beta-adrenergic blockade.
    Verani MS; Nishimura S; Mahmarian JJ; Hays JT; Young JB
    J Heart Lung Transplant; 1994; 13(2):181-93. PubMed ID: 8031798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of new cardiac agents using differential therapeutic criteria].
    Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R
    Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
    Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
    Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
    Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
    Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside.
    Herrmann HC; Ruddy TD; Dec GW; Strauss HW; Boucher CA; Fifer MA
    Circulation; 1987 Jun; 75(6):1214-21. PubMed ID: 2952373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease].
    Thormann J; Mitrovic V; Strasser R; Pitschner HF; Riedel H; Bahavar H; Schlepper M
    Z Kardiol; 1993 Apr; 82(4):211-21. PubMed ID: 8506715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone, Posicor and epinephrine.
    McKay RG; Miller MJ; Ferguson JJ; Momomura S; Sahagian P; Grossman W; Pasternak RC
    J Am Coll Cardiol; 1986 Nov; 8(5):1152-60. PubMed ID: 3760389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The end-systolic pressure-volume relationship in the newborn lamb: effects of loading and inotropic interventions.
    Teitel DF; Klautz R; Steendijk P; van der Velde ET; van Bel F; Baan J
    Pediatr Res; 1991 May; 29(5):473-82. PubMed ID: 1896251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [End-systolic pressure-volume relationships obtained by conductance catheter and transient inferior vena caval occlusion: their clinical usefulness].
    Kameyama T; Asanoi H; Ishizaka S; Nozawa T; Fujita M; Sasayama S
    J Cardiol; 1991; 21(2):473-80. PubMed ID: 1668750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
    Holubarsch C; Pieske B; Hasenfuss G; Just H
    Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
    Chatterjee K; Kereiakes D; Viquerat C; Podolin R
    Am J Cardiol; 1987 Aug; 60(5):37C-41C. PubMed ID: 2956866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.